500087:BOM
Cipla Ltd
₹1 385,00
arrow_downward
-0,29%(-4,00) 1D
4 Sep., 15:30:00 GMT+5:30 · INR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 500087...
Open
₹1 398,00
High
₹1 398,00
Low
₹1 375,85
Mkt. cap
1,12Â bn
Avg. vol.
0,00
Volume
64,50Â k
Dividend
0,94%
Quarterly dividend
₹3,25
Ex-dividend date
05 Jun. 2026
P/E ratio
33,21
52-wk high
₹1 672,20
52-wk low
₹1 165,55
EPS
₹41,70
Shares outstanding
805,67Â m
No. of employees
31Â k
Open
₹1 398,00
High
₹1 398,00
Low
₹1 375,85
Mkt. cap
1,12Â bn
Avg. vol.
0,00
Volume
64,50Â k
Dividend
0,94%
Quarterly dividend
₹3,25
Ex-dividend date
05 Jun. 2026
P/E ratio
33,21
52-wk high
₹1 672,20
52-wk low
₹1 165,55
EPS
₹41,70
Shares outstanding
805,67Â m
No. of employees
31Â k
News stories
From web sources and news partners
Business Standard
·
17 uur gelede
Cipla inks exclusive partnership with Qilu Pharma for commercializing Pembrolizumab in US
TradingView
·
19 uur gelede
Cipla shares slip after Keytruda biosimilar deal with Qilu, as competition worries weigh; Morgan Stanley cautious
TipRanks
·
1 dag gelede
Cipla Strikes Exclusive U.S. Deal for Keytruda Biosimilar with Qilu Pharmaceutical
Profile
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia
About Cipla Ltd
CEOUmang Vohra
Employees31,4Â k
Founded1935
HeadquartersMumbai, Maharashtra, Indië
SectorPharmaceutical industry
Websitecipla.com